About ScienceIO

ScienceIO is a healthcare AI company founded in 2019, focused on converting unstructured medical text into structured data. Using proprietary AI models and APIs, it enhances workflows, decision-making, and patient outcomes. The company is headquartered in New York and Boston and emerged from stealth in 2021, securing $8 million in seed funding. In February 2024, ScienceIO was acquired by Veradigm for $140 million, which will enhance Veradigm's AI capabilities.

The company's flagship product, Structure, allows users to structure medical text efficiently, recognizing over 9 million medical concepts for various applications, including patient anonymization and predictive analytics. ScienceIO's broader AI platform supports healthcare organizations in processing unstructured data into actionable insights, addressing clinical and administrative needs. With a team led by experienced professionals, ScienceIO emphasizes values such as empathy and mission-driven focus, aiming to make healthcare more transparent and equitable.